{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:01:39Z","timestamp":1787032899133,"version":"build-2736575974"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,10]]},"DOI":"10.7759\/cureus.82002","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T08:48:30Z","timestamp":1744274910000},"source":"Crossref","is-referenced-by-count":3,"title":["Infliximab-Induced Pulmonary Sarcoidosis Treated With Upadacitinib: A Case Report and Review of the Literature"],"prefix":"10.7759","author":[{"given":"Ei","family":"Swe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Begun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.semdp.2018.09.001","article-title":"Reprint of: the pathology of pulmonary sarcoidosis: update","volume":"35","author":"Ma Y","year":"2018","unstructured":"Ma Y, Gal A, Koss M. Reprint of: the pathology of pulmonary sarcoidosis: update. Semin Diagn Pathol. 2018, 35:324-33. 10.1053\/j.semdp.2018.09.001","journal-title":"Semin Diagn Pathol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0041-3879(47)80049-2","article-title":"A case of sarcoidosis of the lung with regional ileitis","volume":"28","author":"Morland A","year":"1947","unstructured":"Morland A. A case of sarcoidosis of the lung with regional ileitis. Tubercle. 1947, 28:32. 10.1016\/s0041-3879(47)80049-2","journal-title":"Tubercle"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.03.00040602","article-title":"CARD15 gene mutations in sarcoidosis","volume":"22","author":"Sch\u00fcrmann M","year":"2003","unstructured":"Sch\u00fcrmann M, Valentonyte R, Hampe J, M\u00fcller-Quernheim J, Schwinger E, Schreiber S. CARD15 gene mutations in sarcoidosis. Eur Respir J. 2003, 22:748-54. 10.1183\/09031936.03.00040602","journal-title":"Eur Respir J"},{"key":"ref4","article-title":"Sarcoidosis and Crohn disease in siblings","volume":"104","author":"Willoughby JM","year":"1971","unstructured":"Willoughby JM, Mitchell DN, Wilson JD. Sarcoidosis and Crohn disease in siblings. Am Rev Respir Dis. 1971, 104:249-54.","journal-title":"Am Rev Respir Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13246","article-title":"TNF-\u03b1: a treatment target or cause of sarcoidosis?","volume":"29","author":"Amber KT","year":"2015","unstructured":"Amber KT, Bloom R, Mrowietz U, Hertl M. TNF-\u03b1: a treatment target or cause of sarcoidosis?. J Eur Acad Dermatol Venereol. 2015, 29:2104-11. 10.1111\/jdv.13246","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2019.1615054","article-title":"Synthetic pharmacotherapy for pulmonary sarcoidosis","volume":"20","author":"Llabres M","year":"2019","unstructured":"Llabres M, Brito-Zer\u00f3n P, Ramos-Casals M, Sellares J. Synthetic pharmacotherapy for pulmonary sarcoidosis. Expert Opin Pharmacother. 2019, 20:1397-404. 10.1080\/14656566.2019.1615054","journal-title":"Expert Opin Pharmacother"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2021.08.012","article-title":"Treatment of cutaneous sarcoidosis with tofacitinib: a case report and review of evidence for Janus kinase inhibition in sarcoidosis","volume":"16","author":"Talty R","year":"2021","unstructured":"Talty R, Damsky W, King B. Treatment of cutaneous sarcoidosis with tofacitinib: a case report and review of evidence for Janus kinase inhibition in sarcoidosis. JAAD Case Rep. 2021, 16:62-4. 10.1016\/j.jdcr.2021.08.012","journal-title":"JAAD Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2010.00861.x","article-title":"Sarcoidosis during infliximab therapy for Crohn's disease","volume":"37","author":"Takahashi H","year":"2010","unstructured":"Takahashi H, Kaneta K, Honma M, et al.. Sarcoidosis during infliximab therapy for Crohn's disease. J Dermatol. 2010, 37:471-4. 10.1111\/j.1346-8138.2010.00861.x","journal-title":"J Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2012.01.008","article-title":"Cutaneous sarcoidosis in a patient with ulcerative colitis on infliximab","volume":"6","author":"Fok KC","year":"2012","unstructured":"Fok KC, Ng WW, Henderson CJ, Connor SJ. Cutaneous sarcoidosis in a patient with ulcerative colitis on infliximab. J Crohns Colitis. 2012, 6:708-12. 10.1016\/j.crohns.2012.01.008","journal-title":"J Crohns Colitis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2013.06.002","article-title":"Sarcoidosis during therapy with adalimumab in a Crohn's disease patient: a paradoxical effect","volume":"7","author":"Kotze PG","year":"2013","unstructured":"Kotze PG, de Barcelos IF, da Silva Kotze LM. Sarcoidosis during therapy with adalimumab in a Crohn's disease patient: a paradoxical effect. J Crohns Colitis. 2013, 7:e599-600. 10.1016\/j.crohns.2013.06.002","journal-title":"J Crohns Colitis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.crohns.2014.02.006","article-title":"Sarcoidosis complicating treatment with adalimumab for Crohn's disease","volume":"8","author":"McDonnell MJ","year":"2014","unstructured":"McDonnell MJ, Rutherford RM, O'Regan A. Sarcoidosis complicating treatment with adalimumab for Crohn's disease. J Crohns Colitis. 2014, 8:1140-1. 10.1016\/j.crohns.2014.02.006","journal-title":"J Crohns Colitis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.12.040","article-title":"New-onset paresthesias in inflammatory bowel disease","volume":"148","author":"Simonetto DA","year":"2015","unstructured":"Simonetto DA, Papadakis KA. New-onset paresthesias in inflammatory bowel disease. Gastroenterology. 2015, 148:906-7. 10.1053\/j.gastro.2014.12.040","journal-title":"Gastroenterology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3393\/ac.2017.33.2.74","article-title":"Pulmonary sarcoidosis that developed during the treatment of a patient with Crohn disease by using infliximab","volume":"33","author":"Kim TK","year":"2017","unstructured":"Kim TK, Kang SH, Moon HS, Sung JK, Jeong HY, Eun HS. Pulmonary sarcoidosis that developed during the treatment of a patient with Crohn disease by using infliximab. Ann Coloproctol. 2017, 33:74-7. 10.3393\/ac.2017.33.2.74","journal-title":"Ann Coloproctol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjw155","article-title":"Sarcoidosis-like lesions: another paradoxical reaction to anti-TNF therapy?","volume":"11","author":"Decock A","year":"2017","unstructured":"Decock A, Van Assche G, Vermeire S, Wuyts W, Ferrante M. Sarcoidosis-like lesions: another paradoxical reaction to anti-TNF therapy?. J Crohns Colitis. 2017, 11:378-83. 10.1093\/ecco-jcc\/jjw155","journal-title":"J Crohns Colitis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006156","article-title":"Sarcoidosis associated with infliximab therapy in ulcerative colitis: a case report","volume":"96","author":"G\u00eelc\u0103 GE","year":"2017","unstructured":"G\u00eelc\u0103 GE, Diaconescu S, B\u0103lan GG, Timofte O, \u015etef\u0103nescu G. Sarcoidosis associated with infliximab therapy in ulcerative colitis: a case report. Medicine (Baltimore). 2017, 96:e6156. 10.1097\/MD.0000000000006156","journal-title":"Medicine (Baltimore)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-021-01948-6","article-title":"Development of pulmonary sarcoidosis in Crohn's disease patient under infliximab biosimilar treatment after long-term original infliximab treatment: a case report and literature review","volume":"21","author":"Kashima S","year":"2021","unstructured":"Kashima S, Moriichi K, Ando K, Ueno N, Tanabe H, Yuzawa S, Fujiya M. Development of pulmonary sarcoidosis in Crohn's disease patient under infliximab biosimilar treatment after long-term original infliximab treatment: a case report and literature review. BMC Gastroenterol. 2021, 21:373. 10.1186\/s12876-021-01948-6","journal-title":"BMC Gastroenterol"},{"key":"ref17","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000001240","article-title":"Diagnosis and management of cardiac sarcoidosis: a scientific statement from the American Heart Association","volume":"149","author":"Cheng RK","year":"2024","unstructured":"Cheng RK, Kittleson MM, Beavers CJ, et al.. Diagnosis and management of cardiac sarcoidosis: a scientific statement from the American Heart Association. Circulation. 2024, 149:e1197-216.","journal-title":"Circulation"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202002-0251ST","article-title":"Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline","volume":"201","author":"Crouser ED","year":"2020","unstructured":"Crouser ED, Maier LA, Wilson KC, et al.. Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2020, 201:e26-51. 10.1164\/rccm.202002-0251ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2019-214348","article-title":"BTS clinical statement on pulmonary sarcoidosis","volume":"76","author":"Thillai M","year":"2021","unstructured":"Thillai M, Atkins CP, Crawshaw A, et al.. BTS clinical statement on pulmonary sarcoidosis. Thorax. 2021, 76:4-20. 10.1136\/thoraxjnl-2019-214348","journal-title":"Thorax"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13010015","article-title":"Emerging therapeutic options for refractory pulmonary sarcoidosis: the evidence and proposed mechanisms of action","volume":"13","author":"Nelson NC","year":"2023","unstructured":"Nelson NC, Kogan R, Condos R, Hena KM. Emerging therapeutic options for refractory pulmonary sarcoidosis: the evidence and proposed mechanisms of action. J Clin Med. 2023, 13:15. 10.3390\/jcm13010015","journal-title":"J Clin Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11112","article-title":"Treatment of multiorgan sarcoidosis with tofacitinib","volume":"2","author":"Damsky W","year":"2020","unstructured":"Damsky W, Young BD, Sloan B, Miller EJ, Obando JA, King B. Treatment of multiorgan sarcoidosis with tofacitinib. ACR Open Rheumatol. 2020, 2:106-9. 10.1002\/acr2.11112","journal-title":"ACR Open Rheumatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217271","article-title":"Steroid-resistant sarcoidosis treated with baricitinib","volume":"79","author":"Scheinberg M","year":"2020","unstructured":"Scheinberg M, Maluf F, Wagner J. Steroid-resistant sarcoidosis treated with baricitinib. Ann Rheum Dis. 2020, 79:1259-60. 10.1136\/annrheumdis-2020-217271","journal-title":"Ann Rheum Dis"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01482-2018","article-title":"Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia","volume":"52","author":"Rotenberg C","year":"2018","unstructured":"Rotenberg C, Besnard V, Brillet PY, Giraudier S, Nunes H, Valeyre D. Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia. Eur Respir J. 2018, 52:1801482. 10.1183\/13993003.01482-2018","journal-title":"Eur Respir J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/346653-infliximab-induced-pulmonary-sarcoidosis-treated-with-upadacitinib-a-case-report-and-review-of-the-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T08:48:30Z","timestamp":1744274910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/346653-infliximab-induced-pulmonary-sarcoidosis-treated-with-upadacitinib-a-case-report-and-review-of-the-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":23,"URL":"https:\/\/doi.org\/10.7759\/cureus.82002","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4,10]]}}}